Agree, the most logical outcome is buy-out or solid licensing partnership. I am hopeful and believe that Missling genuinely aim to optimise share holder value.
Things are not always as they appear.. BP probably trying to figure out how to get around Anavex Patent and create similar product. They just use their clout to delay Anavex until they may compete.
I'll tell you what will crush any BP suppression if 273 works....money. First it is worth a fortune to the BP or generic manufacturer who does the deal. More importantly, it is worth $megabillions to governments. They pay for old age care, and they see a demographic tidal wave of old baby boomers on the way. Government can't afford to pay for all those high care nursing homes. Why do you think the govt of Australia was funding our trials? Money, saving billions of it.
News 
Market Data 
Discover 
